Literature DB >> 22163100

The mesopontine rostromedial tegmental nucleus: an integrative modulator of the reward system.

Heather N Lavezzi1, Daniel S Zahm.   

Abstract

The mesopontine rostromedial tegmental nucleus (RMTg) is a newly discovered brain structure thought to profoundly influence reward-related pathways. The RMTg is prominently GABAergic, receives dense projections from the lateral habenula and projects strongly to the midbrain ventral tegmental area and substantia nigra compacta. It receives additional afferent connections from widespread brain structures and sends additional strong efferent connections to a number of non-dopaminergic brainstem structures and, to a lesser extent, the forebrain. Projection neurons of the RMTg have been shown to express Fos in response to aversive stimuli and/or reward omission and psychostimulant drug administration. This review will first recount how the RMTg was discovered and then describe in greater detail what is known about its neuroanatomical relationships, including afferent and efferent connections, neurotransmitters, and receptors. Finally, we will focus on what has been reported about its function.

Entities:  

Year:  2011        PMID: 22163100      PMCID: PMC3233474          DOI: 10.1016/j.baga.2011.08.003

Source DB:  PubMed          Journal:  Basal Ganglia        ISSN: 2210-5336


  89 in total

1.  Negative reward signals from the lateral habenula to dopamine neurons are mediated by rostromedial tegmental nucleus in primates.

Authors:  Simon Hong; Thomas C Jhou; Mitchell Smith; Kadharbatcha S Saleem; Okihide Hikosaka
Journal:  J Neurosci       Date:  2011-08-10       Impact factor: 6.167

Review 2.  Neural mechanisms of freezing and passive aversive behaviors.

Authors:  Thomas Jhou
Journal:  J Comp Neurol       Date:  2005-12-05       Impact factor: 3.215

3.  Glutamatergic axons from the lateral habenula mainly terminate on GABAergic neurons of the ventral midbrain.

Authors:  K Brinschwitz; A Dittgen; V I Madai; R Lommel; S Geisler; R W Veh
Journal:  Neuroscience       Date:  2010-03-29       Impact factor: 3.590

4.  Mapping out of catecholamine and 5-hydroxytryptamine neurons innervating the telencephalon and diencephalon.

Authors:  N E Andén; A Dahlström; K Fuxe; K Larsson
Journal:  Life Sci       Date:  1965-07       Impact factor: 5.037

5.  Effects of amygdala, hippocampus, and periaqueductal gray lesions on short- and long-term contextual fear.

Authors:  J J Kim; R A Rison; M S Fanselow
Journal:  Behav Neurosci       Date:  1993-12       Impact factor: 1.912

6.  The laterodorsal tegmentum contributes to behavioral sensitization to amphetamine.

Authors:  C L Nelson; J B Wetter; M Milovanovic; M E Wolf
Journal:  Neuroscience       Date:  2007-02-22       Impact factor: 3.590

7.  The mesopontine rostromedial tegmental nucleus: A structure targeted by the lateral habenula that projects to the ventral tegmental area of Tsai and substantia nigra compacta.

Authors:  Thomas C Jhou; Stefanie Geisler; Michela Marinelli; Beth A Degarmo; Daniel S Zahm
Journal:  J Comp Neurol       Date:  2009-04-20       Impact factor: 3.215

8.  Colocalization of gamma-aminobutyric acid and acetylcholine in neurons in the laterodorsal and pedunculopontine tegmental nuclei in the cat: a light and electron microscopic study.

Authors:  Hong-Ge Jia; Jack Yamuy; Sharon Sampogna; Francisco R Morales; Michael H Chase
Journal:  Brain Res       Date:  2003-12-05       Impact factor: 3.252

Review 9.  Multiple dopamine functions at different time courses.

Authors:  Wolfram Schultz
Journal:  Annu Rev Neurosci       Date:  2007       Impact factor: 12.449

10.  Dopamine is necessary for cue-dependent fear conditioning.

Authors:  Jonathan P Fadok; Tavis M K Dickerson; Richard D Palmiter
Journal:  J Neurosci       Date:  2009-09-09       Impact factor: 6.167

View more
  25 in total

1.  Mapping of reinforcing and analgesic effects of the mu opioid agonist endomorphin-1 in the ventral midbrain of the rat.

Authors:  Thomas C Jhou; Sheng-Ping Xu; Mary R Lee; Courtney L Gallen; Satoshi Ikemoto
Journal:  Psychopharmacology (Berl)       Date:  2012-06-06       Impact factor: 4.530

Review 2.  Opioid-induced rewards, locomotion, and dopamine activation: A proposed model for control by mesopontine and rostromedial tegmental neurons.

Authors:  Stephan Steidl; David I Wasserman; Charles D Blaha; John S Yeomans
Journal:  Neurosci Biobehav Rev       Date:  2017-09-23       Impact factor: 8.989

3.  Sources of input to the rostromedial tegmental nucleus, ventral tegmental area, and lateral habenula compared: A study in rat.

Authors:  Leora Yetnikoff; Anita Y Cheng; Heather N Lavezzi; Kenneth P Parsley; Daniel S Zahm
Journal:  J Comp Neurol       Date:  2015-06-10       Impact factor: 3.215

Review 4.  Systems level neuroplasticity in drug addiction.

Authors:  Matthew W Feltenstein; Ronald E See
Journal:  Cold Spring Harb Perspect Med       Date:  2013-05-01       Impact factor: 6.915

Review 5.  Regulation of dopamine system responsivity and its adaptive and pathological response to stress.

Authors:  Pauline Belujon; Anthony A Grace
Journal:  Proc Biol Sci       Date:  2015-04-22       Impact factor: 5.349

Review 6.  Braking dopamine systems: a new GABA master structure for mesolimbic and nigrostriatal functions.

Authors:  Michel Barrot; Susan R Sesack; François Georges; Marco Pistis; Simon Hong; Thomas C Jhou
Journal:  J Neurosci       Date:  2012-10-10       Impact factor: 6.167

7.  Localization and behaviors in null mice suggest that ASIC1 and ASIC2 modulate responses to aversive stimuli.

Authors:  M P Price; H Gong; M G Parsons; J R Kundert; L R Reznikov; L Bernardinelli; K Chaloner; G F Buchanan; J A Wemmie; G B Richerson; M D Cassell; M J Welsh
Journal:  Genes Brain Behav       Date:  2013-12-30       Impact factor: 3.449

8.  Comparison of the locomotor-activating effects of bicuculline infusions into the preoptic area and ventral pallidum.

Authors:  Daniel S Zahm; Zachary M Schwartz; Heather N Lavezzi; Leora Yetnikoff; Kenneth P Parsley
Journal:  Brain Struct Funct       Date:  2013-02-20       Impact factor: 3.270

Review 9.  Pharmacological means of reducing human drug dependence: a selective and narrative review of the clinical literature.

Authors:  Shih-Ku Lin
Journal:  Br J Clin Pharmacol       Date:  2014-02       Impact factor: 4.335

10.  Amygdala β-noradrenergic receptors modulate delayed downregulation of dopamine activity following restraint.

Authors:  Chun-hui Chang; Anthony A Grace
Journal:  J Neurosci       Date:  2013-01-23       Impact factor: 6.167

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.